Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Lozano ML, Rodeghiero F. Thrombopoietin receptor agonist in chemotherapy-induced thrombocytopenia. Lancet Haematol. 2022 Mar;9(3):e168-e169. doi: 10.1016/S2352-3026(22)00030-8. No abstract available. PubMed PMID: 35240068.
AÑO: 2022; IF: 24.7
35240068
Gorog DA, Gue YX, Chao TF, Fauchier L, Ferreiro JL, Huber K, Konstantinidis SV, Lane DA, Marin F, Oldgren J, Potpara T, Roldan V, Rubboli A, Sibbing D, Tse HF, Vilahur G, Lip GYH. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. Thromb Haemost. 2022 Oct;122(10):1625-1652. doi: 10.1055/s-0042-1750385. Epub 2022 Jul 6. PubMed PMID: 35793691.
AÑO: 2022; IF: 6.7
35793691
Carmona-Bayonas A, Verso M, Sanchez Canovas M, Rubio Perez J, Garcia de Herreros M, Martinez Del Prado P, Fernandez Perez I, Quintanar Verduguez T, Obispo Portero B, Pachon Olmos V, Gomez D, Ortega L, Serrano Moyano M, M Brozos E, Biosca M, Antonio Rebollo M, Teijeira Sanchez L, Hernandez Perez C, David Cumplido Buron J, Martinez Lago N, Garcia Perez E, Munoz Langa J, Perez Segura P, Martinez de Castro E, Jimenez-Fonseca P, Agnelli G, Munoz A. Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial. Thromb Haemost. 2022 Oct;122(10):1653-1661. doi: 10.1055/a-1816-8347. Epub 2022 Apr 5. PubMed PMID: 35381615; PubMed Central PMCID: PMC9512585.
AÑO: 2022; IF: 6.7
35381615
Orti G, Garcia-Gutierrez V, Bautista G, Ferrer-Marin F, Vallansot R, Xicoy B, Sanchez A, Simon I, Triguero A, Sierra M, Casado LF; Grupo Espanol de Leucemia Mieloide Cronica (GELMC). Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia. Leuk Res. 2022 Oct;121:106923. doi: 10.1016/j.leukres.2022.106923. Epub 2022 Aug 4. No abstract available. PubMed PMID: 35933910.
AÑO: 2022; IF: 2.7
35933910
Triguero A, Pedraza A, Perez-Encinas M, Mata-Vazquez MI, Velez P, Fox L, Gomez-Calafat M, Garcia-Delgado R, Gasior M, Ferrer-Marin F, Garcia-Gutierrez V, Angona A, Gomez-Casares MT, Cuevas B, Martinez C, Perez R, Raya JM, Guerrero L, Murillo I, Bellosillo B, Hernandez-Boluda JC, Sanz C, Alvarez-Larran A; On behalf of the MPN Spanish Group (GEMFIN). Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera. Ann Hematol. 2022 Oct;101(10):2231-2239. doi: 10.1007/s00277-022-04963-z. Epub 2022 Aug 30. Erratum In: Ann Hematol. 2022 Dec;101(12):2819-2820. PubMed PMID: 36042023; PubMed Central PMCID: PMC9584989.
AÑO: 2022; IF: 3.5
36042023
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL